Luigi Mangione, a 28-year-old man accused of killing UnitedHealthcare’s chief executive officer, Brian Thompson, has pleaded guilty to federal charges related to the murder. The sentencing hearing is scheduled for December 18, according to court documents. Thompson was shot dead in New York City in December 2024, and Mangione admitted during his plea hearing that he fired the fatal shots. He stated that he knew his actions were illegal. The incident occurred when Mangione, who had traveled to Manhattan in November 2024, sent an email to UnitedHealthcare’s leadership posing as an investor managing over $15 billion in assets. He requested information about a conference, and unlike previous interactions with insurance companies, he received a prompt response within less than an hour. During the plea hearing, Mangione described these steps before carrying out the attack. Federal Judge Margaret Garnett asked Mangione how he stood regarding counts one and two of the indictment. Mangione responded, “Guilty.” Garnett accepted the plea. According to reports, Mangione will remain in federal custody until the sentencing date, which is set for 11 a.m. on Friday, December 18. During the hearing, the judge indicated that if either party intended to call witnesses during the sentencing hearing, they should notify her two weeks in advance. Mangione left the courtroom after completing the proceedings, having formally entered his plea. Mangione’s defense team has filed a motion requesting the dismissal of state homicide charges related to the case. This request came after Mangione entered his guilty plea in the federal case, separate from the ongoing state trial in New York. His attorneys argue that Mangione should not face a second trial for the same act. They believe this would be unfair and redundant. Federal prosecutors, including U.S. Attorney Jamie McDonald for the Southern District of New York, emphasized that Mangione’s plea was open and unconditional. He admitted guilt to all pending charges in the indictment. There were no concessions or agreements reached, and prosecutors have the authority to seek the maximum penalty allowed by law. Mangione’s statement during the plea hearing included the admission that he shot Thompson, resulting in his death. He acknowledged the illegality of his actions. The motive cited in the indictment was retaliation against the U.S. healthcare insurance system, though specific details of Mangione’s grievances were not elaborated upon during the hearing. The case has drawn significant attention due to the high-profile nature of the victim, Brian Thompson, who was the CEO of UnitedHealth Group, the largest health insurer in the United States. Thompson was killed while walking in New York City, an act that shocked the public and raised questions about security measures for corporate executives. The federal plea deal does not address the state charges, which are still under consideration. The defense continues to push for their dismissal, arguing that Mangione should not be subjected to double jeopardy. Meanwhile, federal authorities are preparing for the sentencing, which could result in a lengthy prison term given the severity of the crime. The case highlights the complex legal landscape surrounding high-profile murders and the potential for overlapping federal and state jurisdictions. As the December 18 sentencing date approaches, both sides are likely to prepare extensively for the proceeding, with prosecutors seeking the harshest penalties and the defense focusing on mitigating factors. Mangione’s mental state at the time of the crime, previously described by his defense as experiencing extreme emotional disturbance, may play a role in the sentencing decision.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter
MX
